{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:55:32Z","timestamp":1789973732825,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.dld.2008.09.021","type":"journal-article","created":{"date-parts":[[2008,11,26]],"date-time":"2008-11-26T13:34:41Z","timestamp":1227706481000},"page":"417-423","source":"Crossref","is-referenced-by-count":17,"title":["Pro-inflammatory Interleukin-18 and Caspase-1 serum levels in liver failure are unaffected by MARS treatment"],"prefix":"10.1016","volume":"41","author":[{"given":"G.A.","family":"Roth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Faybik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Hetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Hacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.J.","family":"Ankersmit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Thalhammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.G.","family":"Krenn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2008.09.021_bib1","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/hep.20703","article-title":"AASLD position paper: the management of acute liver failure","volume":"41","author":"Polson","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2008.09.021_bib2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-2006-945528","article-title":"Intensive management of hepatic failure","volume":"27","author":"Rinella","year":"2006","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.dld.2008.09.021_bib3","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1053\/jlts.2001.29108","article-title":"Hemodynamic changes during a single treatment with the molecular adsorbents recirculating system in patients with acute-on-chronic liver failure","volume":"7","author":"Schmidt","year":"2001","journal-title":"Liver Transplant"},{"key":"10.1016\/j.dld.2008.09.021_bib4","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1053\/jlts.2003.50051","article-title":"Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: a prospective controlled trial","volume":"9","author":"Schmidt","year":"2003","journal-title":"Liver Transplant"},{"key":"10.1016\/j.dld.2008.09.021_bib5","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/lt.20236","article-title":"Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study","volume":"10","author":"Sen","year":"2004","journal-title":"Liver Transplant"},{"key":"10.1016\/j.dld.2008.09.021_bib6","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1572-0241.2005.40864.x","article-title":"Emerging indications for albumin dialysis","volume":"100","author":"Sen","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2008.09.021_bib7","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/lt.20323","article-title":"Binding of bilirubin and bromosulphthalein to albumin: implications for understanding the pathophysiology of liver failure and its management","volume":"10","author":"Steiner","year":"2004","journal-title":"Liver Transplant"},{"key":"10.1016\/j.dld.2008.09.021_bib8","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1053\/jhep.2002.36130","article-title":"Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study","volume":"36","author":"Heemann","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2008.09.021_bib9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/lv.2000.6355","article-title":"Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial","volume":"6","author":"Mitzner","year":"2000","journal-title":"Liver Transplant"},{"issue":"Suppl 2","key":"10.1016\/j.dld.2008.09.021_bib10","first-page":"7","article-title":"Cytokines and liver failure: modification of TNF- and IL-6 in patients with acute on chronic liver decompensation treated with molecular adsorbent recycling system (MARS)","volume":"74","author":"Ambrosino","year":"2003","journal-title":"Acta Biomed"},{"issue":"Suppl 3","key":"10.1016\/j.dld.2008.09.021_bib11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1034\/j.1478-3231.23.s.3.7.x","article-title":"Application of Molecular Adsorbents Recirculating System to remove NO and cytokines in severe liver failure patients with multiple organ dysfunction syndrome","volume":"23","author":"Guo","year":"2003","journal-title":"Liver Int"},{"issue":"Suppl 1","key":"10.1016\/j.dld.2008.09.021_bib12","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1097\/00002371-200203001-00013","article-title":"Increased concentrations of plasma interleukin-18 in patients with hepatic failure 1 week after surgery","volume":"25","author":"Hirota","year":"2002","journal-title":"J Immunother (1997)"},{"key":"10.1016\/j.dld.2008.09.021_bib13","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1111\/j.1440-1746.2006.04376.x","article-title":"Increased serum and hepatic tissue levels of interleukin-18 in patients with fulminant hepatic failure","volume":"21","author":"Shinoda","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2008.09.021_bib14","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.semnephrol.2006.09.013","article-title":"Interleukin-18 and the pathogenesis of inflammatory diseases","volume":"27","author":"Dinarello","year":"2007","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.dld.2008.09.021_bib15","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1034\/j.1600-0528.2002.017418.x","article-title":"Pathophysiological roles of interleukin-18 in inflammatory liver diseases","volume":"174","author":"Tsutsui","year":"2000","journal-title":"Immunol Rev"},{"key":"10.1016\/j.dld.2008.09.021_bib16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1034\/j.1600-065X.2003.00048.x","article-title":"Caspase-activation pathways in apoptosis and immunity","volume":"193","author":"Creagh","year":"2003","journal-title":"Immunol Rev"},{"key":"10.1016\/j.dld.2008.09.021_bib17","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000090411","article-title":"Plasma interleukin-18 levels in hemodialysis patients: increased by dialysis process and association with interleukin-6 and tumor necrotic factor-alpha","volume":"24","author":"Chiang","year":"2006","journal-title":"Blood Purif"},{"key":"10.1016\/j.dld.2008.09.021_bib18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1525-1594.2002.06822.x","article-title":"The molecular adsorbents recycling system as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers","volume":"26","author":"Stange","year":"2002","journal-title":"Artif Organs"},{"key":"10.1016\/j.dld.2008.09.021_bib19","doi-asserted-by":"crossref","first-page":"R24","DOI":"10.1186\/cc3985","article-title":"Molecular adsorbent recirculating system and hemostasis in patients at high risk of bleeding: an observational study","volume":"10","author":"Faybik","year":"2006","journal-title":"Crit Care"},{"key":"10.1016\/j.dld.2008.09.021_bib20","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00535-007-2029-9","article-title":"Systemic inflammatory response syndrome strongly affects the prognosis of patients with fulminant hepatitis B","volume":"42","author":"Miyake","year":"2007","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.dld.2008.09.021_bib21","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/jhep.2000.17687","article-title":"The systemic inflammatory response syndrome in acute liver failure","volume":"32","author":"Rolando","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2008.09.021_bib22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jhep.2003.10.016","article-title":"Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis","volume":"40","author":"Shawcross","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2008.09.021_bib23","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1056\/NEJM200011163432007","article-title":"Cytokines in alcoholic and nonalcoholic steatohepatitis","volume":"343","author":"Tilg","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2008.09.021_bib24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000069395","article-title":"Involvement of IL-18 and soluble fas in patients with postoperative hepatic failure","volume":"35","author":"Nakae","year":"2003","journal-title":"Eur Surg Res"},{"key":"10.1016\/j.dld.2008.09.021_bib25","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1525-1594.2005.29054.x","article-title":"Effectiveness of combining plasma exchange and continuous hemodiafiltration in patients with postoperative liver failure","volume":"29","author":"Yonekawa","year":"2005","journal-title":"Artif Organs"},{"key":"10.1016\/j.dld.2008.09.021_bib26","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.4049\/jimmunol.159.8.3961","article-title":"IL-18 accounts for both TNF-alpha- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice","volume":"159","author":"Tsutsui","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.dld.2008.09.021_bib27","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1111\/j.1572-0241.2005.00265.x","article-title":"Expression of Fas ligand by hepatic macrophages in patients with fulminant hepatic failure","volume":"100","author":"Mita","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2008.09.021_bib28","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/S0140-6736(05)78614-1","article-title":"Raised plasma soluble Fas and Fas-ligand in alcoholic liver disease","volume":"351","author":"Taieb","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2008.09.021_bib29","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/intimm\/11.3.471","article-title":"IL-18-deficient mice are resistant to endotoxin-induced liver injury but highly susceptible to endotoxin shock","volume":"11","author":"Sakao","year":"1999","journal-title":"Int Immunol"},{"key":"10.1016\/j.dld.2008.09.021_bib30","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1126\/science.275.5297.206","article-title":"Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme","volume":"275","author":"Gu","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.dld.2008.09.021_bib31","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2362.2007.01803.x","article-title":"Elevated levels of interleukin-1beta-converting enzyme and caspase-cleaved cytokeratin-18 in acute myocardial infarction","volume":"37","author":"Adlbrecht","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.dld.2008.09.021_bib32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/hrt.2003.012062","article-title":"Increased serum concentrations of soluble CD95\/Fas and caspase 1\/ICE in patients with acute angina","volume":"90","author":"Ankersmit","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.dld.2008.09.021_bib33","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0006-291X(03)01389-5","article-title":"Aberrant T cell activation and heightened apoptotic turnover in end-stage renal failure patients: a comparative evaluation between non-dialysis, haemodialysis, and peritoneal dialysis","volume":"308","author":"Moser","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.dld.2008.09.021_bib34","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0006-291X(03)01482-7","article-title":"Susceptibility to programmed cell death in T-lymphocytes from septic patients: a mechanism for lymphopenia and Th2 predominance","volume":"308","author":"Roth","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.dld.2008.09.021_bib35","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S0960-9822(02)70688-X","article-title":"ICE inhibitor YVADcmk is a potent therapeutic agent against in vivo liver apoptosis","volume":"6","author":"Rouquet","year":"1996","journal-title":"Curr Biol"},{"key":"10.1016\/j.dld.2008.09.021_bib36","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1111\/j.1440-1746.2007.04960.x","article-title":"Improvement of the survival rate after rat massive hepatectomy due to the reduction of apoptosis by caspase inhibitor","volume":"22","author":"Yoshida","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2008.09.021_bib37","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1046\/j.1365-2249.2001.01590.x","article-title":"Impaired T cell proliferation, increased soluble death-inducing receptors and activation-induced T cell death in patients undergoing haemodialysis","volume":"125","author":"Ankersmit","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.dld.2008.09.021_bib38","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0140-6736(98)10359-8","article-title":"Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device","volume":"354","author":"Ankersmit","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2008.09.021_bib39","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1016\/j.transproceed.2006.10.058","article-title":"Albumin dialysis has no clear effect on cytokine levels in patients with life-threatening liver insufficiency","volume":"38","author":"Ilonen","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.dld.2008.09.021_bib40","doi-asserted-by":"crossref","first-page":"R169","DOI":"10.1186\/cc5119","article-title":"Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failure","volume":"10","author":"Stadlbauer","year":"2006","journal-title":"Crit Care"},{"key":"10.1016\/j.dld.2008.09.021_bib41","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1006\/cyto.2000.0740","article-title":"Increased concentrations of plasma IL-18 in patients with hepatic dysfunction after hepatectomy","volume":"12","author":"Shibata","year":"2000","journal-title":"Cytokine"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865808006713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865808006713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T13:59:06Z","timestamp":1684677546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865808006713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S1590865808006713"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2008.09.021","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}